Evaluation of the effect of GCSF injection in treatment of COVID-19 patients with lymphopenia

Phase 1

Recruiting

• Conditions: Covid-19.; Coronavirus infection, unspecified; U07.01

• Registration Number: IRCT20200502047268N1
• Lead Sponsor: Semnan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

COVID-19 pneumonia
Conscious consent of the patient

Exclusion Criteria

Without lymphopenia

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood lymphocytes. Timepoint: Befor entering the study and 3 days after drug injection. Method of measurement: Using hemocytometer.